| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.76B | 22.57B | 21.40B | 20.62B | 19.15B | 17.58B |
| Gross Profit | 14.35B | 14.53B | 14.32B | 13.95B | 13.11B | 11.58B |
| EBITDA | 5.70B | 4.73B | 6.53B | 6.53B | 6.19B | 5.43B |
| Net Income | 4.08B | 3.51B | 2.75B | 2.36B | 313.00M | 2.07B |
Balance Sheet | ||||||
| Total Assets | 41.44B | 42.67B | 41.01B | 42.68B | 40.99B | 40.21B |
| Cash, Cash Equivalents and Short-Term Investments | 16.67B | 17.25B | 16.77B | 19.49B | 18.38B | 16.60B |
| Total Debt | 14.81B | 13.50B | 13.15B | 16.36B | 15.75B | 15.13B |
| Total Liabilities | 19.19B | 18.50B | 18.84B | 22.05B | 21.92B | 20.23B |
| Stockholders Equity | 22.19B | 24.10B | 22.10B | 20.54B | 19.01B | 19.92B |
Cash Flow | ||||||
| Free Cash Flow | 3.94B | 3.90B | 3.26B | 3.67B | 3.37B | 3.95B |
| Operating Cash Flow | 5.02B | 4.91B | 4.44B | 4.70B | 4.31B | 4.87B |
| Investing Cash Flow | -2.24B | -1.57B | -1.55B | -2.56B | -1.97B | -2.47B |
| Financing Cash Flow | -2.78B | -4.36B | -2.55B | -1.82B | -2.25B | -1.78B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $116.48B | 15.20 | 18.56% | 0.82% | 13.22% | ― | |
67 Neutral | $28.11B | 20.44 | 106.44% | 1.16% | 14.13% | -15.62% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | $958.09M | -6.74 | 34.58% | ― | 194.57% | ― | |
56 Neutral | $3.23B | 3.75 | 16.38% | 1.46% | 1.64% | ― | |
54 Neutral | $1.11B | 17.42 | 17.42% | ― | 17.16% | -48.49% | |
51 Neutral | $2.20B | 6.45 | -244.66% | ― | -19.81% | 45.85% |